<DOC>
	<DOCNO>NCT02321176</DOCNO>
	<brief_summary>There blood-eye barrier eye , oral medicine enter tissue eye . The primary objective study study Pharmacokinetics Trans-resveratrol Its three Metabolites Human Eyes Blood</brief_summary>
	<brief_title>Pharmacokinetics Trans-resveratrol Based Nutritional Supplement Its Three Metabolites Human Eyes Blood</brief_title>
	<detailed_description>This single-blind , randomise study investigate single oral dose LONGEVINEX two group 20 Patients rhegmatogenous retinal detachment retinal detachmentï¼ˆmales female ) .The subject receive 100mg LONGEVINEX everyday , total three day surgery .</detailed_description>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>1 . Patients rhegmatogenous retinal detachment . 2 . Male female patient 1860 year age . 3. nonsmoker smoke &lt; 10 cigarettes/day . 4 . BMI range 19 30 kg/m^2 eligible study . 5 . Patients consider healthy basis electrocardiogram ( ECG ) , clinical laboratory safety test ( haematology , plasma biochemistry , urinalysis hepatitis B , hepatitis C HIV serology ) perform screen . 6 . Women use measure avoid conception study period ( e.g . oral contraceptive , intrauterine device [ IUDs ] , condom ) . 7 . Avoid ingest grapefruit , grapefruit juice grapefruit juice contain product , herbalbased nutrient supplement prescribe medication ( grapefruit , cranberry , blueberry product , peanut peanut butter , grape grape product , red wine ) period time . 8. patient abstain alcoholcontaining beverage least two day prior study . 1 . Uncontrolled Blood pressure exceed diastolic pressure 100 mm Hg ( sit ) screen period uncontrolled diabetes mellitus 2 . Participation another simultaneous medical investigation trial 3 . Renal failure require dialysis renal transplant liver dysfunction History disease , finding give reasonable suspicion disease condition contraindicate use investigational drug , might affect interpretation result study , render subject high risk treatment complications.5.IOP 30 mmHg . 4 . Any previous retinal laser photocoagulation study eye treatment naive . Any previous intravitreal injection study eye ( triamcinolone ) treatment naive . 5 . Any previous vitrectomy study eye ( posterior anterior associate vitreous loss cataract surgery ) . Intracapsular cataract extraction ( posterior capsule need present ) . 6 . Aphakia absence posterior capsule study eye , Structural damage center macula study eye preexist CRVO likely preclude improvement visual acuity follow resolution macular edema , include atrophy retinal pigment epithelium , subretinal fibrosis , laser scar ( ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>